- GE HealthCare benefits from the trend of onshoring and tariffs associated with the Trump administration.
- The White House threatened new tariffs on Canadian imports, highlighting the healthcare sector's reliance on integrated Canadian supply chains.
- The White House threatened tariffs on Canadian imports, highlighting the healthcare sector's reliance on integrated Canadian supply chains.
The White House announced new tariffs on Canadian imports while noting integrated supply chains and drug price headwinds affecting the healthcare sector.
1 report, 1 independent
Updated Jul 12
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
The White House announced new tariffs on Canadian imports while noting integrated supply chains and drug price headwinds affecting the healthcare sector.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- The White House announced sharp escalation in trade tensions, impacting the healthcare sector and leading to analyst notes on upcoming expenses.Sub-event
Specific companies like Moderna and Intuitive Surgical face policy headwinds amid tariff threats.1 source
Keep exploring
Part of
The White House threatened tariffs on Canadian imports, highlighting the healthcare sector's reliance on integrated Canadian supply chains.Also in this story
- Healthcare companies, including UnitedHealth Group, face market decline due to trade tensions and tariff threats on Canadian imports.
- FDA approved Moderna's Spikevax for high-risk children amid White House tariff threats on Canadian imports.
The entities involved
- White House
-
UnitedHealth Group
for-profit health care company
-
Moderna
American biotechnology company
Related events
- Sun Pharmaceutical Industries agreed to lower US drug prices in exchange for tariff concessions from the US government.
- HHS and the White House are involved in policy discussions regarding generic drugs, including potential agreements concerning U.S. tariffs and the tardive dyskinesia market.
- The White House levied tariffs on Canada, Trump proclaimed sanctions against Iran, and market analysts compared SpaceX's rally to Nvidia's performance.
- Vaccine trial successes boosted Moderna and Merck, while investors awaited Fed minutes amid geopolitical uncertainty in the Middle East and disappointing OpenAI results.
- The US administration announced on September 8, 2026, that it was banning specific goods originating from Canada.
Coverage
Newest first; wire copies grouped- StockStoryU.S. Physical Therapy, Evolent Health, Charles River Laboratories, Moderna, and Intuitive Surgical Shares Are Falling, What You Need To Know A number of stocks fell in the morning session after the U